Tumor lysis syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Tumor lysis syndrome (TLS) may be classified according to the 1993 Hande-Garrow classification system into two groups: laboratory tumor lysis syndrome (LTLS) and clinical tumor lysis syndrome (CTLS).

Classification

Tumor lysis syndrome may be classified according to the 1993 Hande-Garrow classification system into two groups:^[1]^[2]

Laboratory tumor lysis syndrome: patients have positive laboratory findings with no signs or symptoms
Clinical tumor lysis syndrome: patients have life threatening medical signs and require urgent medical interventions

References

↑ Cairo MS, Bishop M (October 2004). “Tumour lysis syndrome: new therapeutic strategies and classification”. Br. J. Haematol. 127 (1): 3–11. doi:10.1111/j.1365-2141.2004.05094.x. PMID 15384972.
↑ Jeha S (October 2001). “Tumor lysis syndrome”. Semin. Hematol. 38 (4 Suppl 10): 4–8. PMID 11694945.

Template:WH Template:WS

[pmid153849722-1] Cairo MS, Bishop M (October 2004). “Tumour lysis syndrome: new therapeutic strategies and classification”. Br. J. Haematol. 127 (1): 3–11. doi:10.1111/j.1365-2141.2004.05094.x. PMID 15384972.

[pmid11694945-2] Jeha S (October 2001). “Tumor lysis syndrome”. Semin. Hematol. 38 (4 Suppl 10): 4–8. PMID 11694945.

[1]

[2]

Tumor lysis syndrome classification

Overview

Classification

References

Looking for the patient version?